World Journal of Endocrine Surgery

Register      Login

VOLUME 6 , ISSUE 2 ( May-August, 2014 ) > List of Articles

EDITORIAL

Parafibromin as a Tool of Screening in Parathyroid Neoplasms

Narendra Krishnani

Citation Information : Krishnani N. Parafibromin as a Tool of Screening in Parathyroid Neoplasms. World J Endoc Surg 2014; 6 (2):0-0.

DOI: 10.5005/wjoes-6-2-v

License: CC BY-NC 4.0

Published Online: 01-08-2014

Copyright Statement:  Copyright © 2014; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract


PDF Share
  1. Clinical course of metastatic parathyroid cancer. World J Surg 1994 Jul-Aug;18:594-598.
  2. Molecular diagnosis of primary hyperparathyroidism in familial cancer syndromes. Expert Opin Med Diagn 2007 Nov;1(3):377-392.
  3. Accuracy of combined protein gene product 9.5 and parafibromin markers for immunohistochemical diagnosis of parathyroid carcinoma. J Clin Endocrinol Metab 2009 Feb;94(2):434-441.
  4. Endocr Relat Cancer 2012 May 24;19(3):389-407.
  5. Large parathyroid tumors have an increased risk of atypia and carcinoma. Am J Surg 2011 Aug;202(2):146-150.
  6. Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma. Clin Cancer Res 2004 Oct 1;10(19):6629-6637.
  7. Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias. Am J Surg Pathol 2006;30:1140-1149.
  8. Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Engl J Med 2003 Oct;349(18):1722-1729.
  9. HRPT2 mutations are associated with malignancy in sporadic parathyroid tumors. J Med Genet 2003 Sep;40(9):657-663.
  10. The parafibromin tumor suppressor protein inhibits cell proliferation by repression of the cmyc proto-oncogene. Proc Natl Acad Sci USA 2008 Nov 11;105(45):17420-17425.
  11. Parathyroid carcinoma. A study of 70 cases. Cancer 1973 Mar;31(3):600-605.
  12. Parafibromin immunoreactivity: its use as an additional diagnostic marker for parathyroid tumor classification. Endocr Relat Cancer 2007 Jun;14(2):501-512.
  13. Parathyroid carcinoma: increasing incidence and changing presentation. ANZ J Surg 2011 Jul-Aug;81(7-8):528-532.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.